Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton May 19, 2015 4:30pm

174 Views

Post# 23742239

RE:RE:Why you should NOT trade RVX (Resverlogix)

just when i had thought all the fraudsters had moved on over to the agorascam site hoity toity (a fraudster who likes to make up fake NR's to try and rube newbies) is back fraud posting...his claim of "14 years of success" i pure WABS why just a while ago RVX ASSURE trial failed to meet its endpoints and RVX crashed over 90% in a matter of minutes...why do these fraudsters always lie every time they post

Bullboard Posts

Thesis Gold makes high-grade discovery at Ring Zone